Trial · NCT03467217
Outcomes17
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
1 to 17 of 17
Download this page as JSON| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Change in Serum Alanine Aminotransferase (ALT) From Baseline. | Baseline and 24 weeks | Results based on complete case analysis. | U/L | MEAN |
| SECONDARY | Change in Gamma-glutamyl Transpeptidase (GGT) Compared to Baseline | Baseline and 24 weeks | U/L | MEAN | |
| SECONDARY | Change in Serum Aspartate Aminotransferase AST at 24 Weeks Compared to Baseline AST | Baseline and 24 weeks | U/L | MEAN | |
| SECONDARY | Relative Change in Serum Alanine Aminotransferase (ALT) Compared to Baseline ALT | Baseline and 24 weeks | percentage of change | MEAN | |
| SECONDARY | Change in ALT at 12 Weeks Compared to Baseline ALT | Baseline and 12 weeks | mg/dL | MEAN | |
| SECONDARY | Change in Homeostatic Model Assessment of Insulin Resistance (HOMA-IR) Compared to Baseline. | Baseline and 24 weeks | mg/dL x uU/mL/405 | MEAN | |
| SECONDARY | Change in Weight at 24 Weeks Compared to Baseline | Baseline and 24 weeks | kg | MEAN | |
| SECONDARY | Change in Body Mass Index (BMI) at 24 Weeks Compared to Baseline. | Baseline and 24 weeks | kg/m^2 | MEAN | |
| SECONDARY | Change in Waist Circumference at 24 Weeks Compared to Baseline | Baseline and 24 weeks | cm | MEAN | |
| SECONDARY | Change in Waist-to-hip Ratio at 24 Weeks Compared to Baseline | Baseline and 24 weeks | ratio | MEAN | |
| SECONDARY | Change in Pediatric Quality of Life Inventory (PedsQOL) Physical Health Score at 24 Weeks Compared to Baseline | Baseline and 24 weeks | score on a scale | MEAN | |
| SECONDARY | Frequency of Adverse Events Over 24 Weeks | Baseline and 24 weeks | adverse events | NUMBER | |
| SECONDARY | Change in Total Cholesterol at 24 Weeks Compared to Baseline | Baseline and 24 weeks | mg/dL | MEAN | |
| SECONDARY | Change in Triglycerides at 24 Weeks Compared to Baseline | Baseline and 24 weeks | mg/dL | MEAN | |
| SECONDARY | Change in HDL Cholesterol at 24 Weeks Compared to Baseline | Baseline and 24 weeks | mg/dL | MEAN | |
| SECONDARY | Change in LDL Cholesterol at 24 Weeks Compared to Baseline | Baseline and 24 weeks | mg/dL | MEAN | |
| SECONDARY | Change in Pediatric Quality of Life Inventory (PedsQOL) Psychosocial Health Score at 24 Weeks Compared to Baseline | Baseline and 24 weeks | score on a scale | MEAN |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03467217/outcomes